These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

576 related articles for article (PubMed ID: 18024988)

  • 41. Beyond mammography screening: quality assurance in breast cancer diagnosis (The QuaMaDi Project).
    Katalinic A; Bartel C; Raspe H; Schreer I
    Br J Cancer; 2007 Jan; 96(1):157-61. PubMed ID: 17179994
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Differential diagnosis of benign and malignant mammary lesions with special regard to the BI-RADS((R)) classification system in mammography].
    Boehm T; Garzoli E; Marincek B
    Gynakol Geburtshilfliche Rundsch; 2002; 42(4):191-200. PubMed ID: 12373023
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Experience with the European quality assurance guidelines for digital mammography systems in a national screening programme.
    McCullagh J; Keavey E; Egan G; Phelan N
    Radiat Prot Dosimetry; 2013 Feb; 153(2):223-6. PubMed ID: 23173219
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Breast Cancer Screening, Mammography, and Other Modalities.
    Fiorica JV
    Clin Obstet Gynecol; 2016 Dec; 59(4):688-709. PubMed ID: 27741212
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quality assurance audits of community screening mammography practices: availability of active follow-up for data collection and outcome assessment.
    Brown ML; Houn F
    AJR Am J Roentgenol; 1994 Oct; 163(4):825-9. PubMed ID: 8092017
    [TBL] [Abstract][Full Text] [Related]  

  • 46. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition--Annotations of colorectal lesions.
    Vieth M; Quirke P; Lambert R; von Karsa L; Risio M;
    Endoscopy; 2012 Sep; 44 Suppl 3():SE131-9. PubMed ID: 23012116
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cost-effectiveness analysis of a quality-controlled mammography screening program from the Swiss statutory health-care perspective: quantitative assessment of the most influential factors.
    Neeser K; Szucs T; Bulliard JL; Bachmann G; Schramm W
    Value Health; 2007; 10(1):42-53. PubMed ID: 17261115
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Auditing and benchmarks in screening and diagnostic mammography.
    Feig SA
    Radiol Clin North Am; 2007 Sep; 45(5):791-800, vi. PubMed ID: 17888769
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Impact of breast ultrasound screening in gynecological practice].
    Madjar H; Becker S; Doubek K; Horchler T; Mendoza M; Moisidis-Tesch C; Näther B; Niebling K; Pröls U; Schardt AR; Ulrich S; Zahn U
    Ultraschall Med; 2010 Jun; 31(3):289-95. PubMed ID: 20408119
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preoperative clinical pathway of breast cancer patients: determinants of compliance with EUSOMA quality indicators.
    Héquet D; Huchon C; Baffert S; Alran S; Reyal F; Nguyen T; Combes A; Trichot C; Alves K; Berseneff H; Rouzier R
    Br J Cancer; 2017 May; 116(11):1394-1401. PubMed ID: 28441385
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Assessment of mammography screening and its introduction in Germany in the Statutory Early Diagnosis Program].
    von Fournier D
    Zentralbl Gynakol; 1999; 121(3):159-65. PubMed ID: 10209861
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quality assurance in mammography. Accreditation, legislation, and compliance with quality assurance standards.
    Hendrick RE
    Radiol Clin North Am; 1992 Jan; 30(1):243-55. PubMed ID: 1732931
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Quality assurance in organized screening of breast cancer].
    De Landtsheer JP; Delaloye JF; Lepori D; De Grandi P; Levi F
    Rev Med Suisse Romande; 2003 May; 123(5):283-9. PubMed ID: 15095710
    [TBL] [Abstract][Full Text] [Related]  

  • 54. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition--Organisation.
    Malila N; Senore C; Armaroli P;
    Endoscopy; 2012 Sep; 44 Suppl 3():SE31-48. PubMed ID: 23012121
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Simulation of breast cancer screening: quality assessment of two protocols.
    Carter KJ; Castro F; Kessler E; Erickson BA
    J Healthc Qual; 2004; 26(6):31-8. PubMed ID: 15603093
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Fine needle aspiration cytology of mammography screening].
    Engvad B; Laenkholm AV; Schwartz W; Bak M
    Ugeskr Laeger; 2009 Aug; 171(34):2379-82. PubMed ID: 19732519
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role and evaluation of mammography and other imaging methods for breast cancer detection, diagnosis, and staging.
    Feig SA
    Semin Nucl Med; 1999 Jan; 29(1):3-15. PubMed ID: 9990680
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Controversies in breast cancer screening for women aged 40-49 years.
    Suzuki A; Ishida T; Ohuchi N
    Jpn J Clin Oncol; 2014 Jul; 44(7):613-8. PubMed ID: 24821976
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of early performance indicators for screening projects within the European Breast Cancer Network: 1989-2000.
    Broeders MJ; Scharpantgen A; Ascunce N; Gairard B; Olsen AH; Mantellini P; Mota TC; Van Limbergen E; Séradour B; Ponti A; Trejo LS; Nyström L;
    Eur J Cancer Prev; 2005 Apr; 14(2):107-16. PubMed ID: 15785314
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Regarding trends in recall, biopsy, and positive biopsy rates for screening mammography.
    Ellis RL
    Radiology; 2006 Jan; 238(1):375-6; author reply 376. PubMed ID: 16373783
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.